Search Results 11-20 of 835 for 2024vadodara
Dr. Roberts' laboratory has made major, unique and widely acknowledged contributions to the understanding and treatment of hepatocellular.
About this study. This randomized phase III trial studies the best dose of apixaban and how well it works in preventing secondary cancer related blood clots ...
About this study. This study is designed to assess the efficacy, safety and tolerability of ixmyelocel-T compared to placebo (vehicle control) when ...
Associate program director, Urologic Oncology Fellowship (Minnesota), 2024-present. · First place, Segura Award, Resident Manuscript Contest, 2019. · Mayo Clinic ...
Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!